Tele-Pulmonary Rehabilitation For Patients With Chronic Lung Diseases
TELE-PRIME
1 other identifier
interventional
90
1 country
2
Brief Summary
Pulmonary rehabilitation is a key treatment for lung diseases, but many patients struggle to attend sessions due to travel distances, physical limitations, or logistical barriers. The purpose of this study is to evaluate whether a tele-pulmonary rehabilitation (TPR) program can improve the rates of treatment initiation and adherence among patients with chronic lung diseases compared to traditional, center-based pulmonary rehabilitation. Additionally, the study will assess improvements in quality of life, physical symptoms, and safety in both groups. This study will enroll 90 patients from two medical centers in Israel (Tel Aviv and Barzilai). Participants will be randomly assigned to one of two groups:
- 1.The control group will receive usual care with a referral by a pulmonologist to standard pulmonary rehabilitation at a medical center.
- 2.The intervention group will participate in a supervised remote tele-rehabilitation program using a dedicated application and remote monitoring.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2026
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2026
CompletedFirst Posted
Study publicly available on registry
June 24, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
June 24, 2026
June 1, 2026
2 years
June 18, 2026
June 18, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Adherence to pulmonary rehabilitation Between the Study Groups
Adherence will be defined as initiation of pulmonary rehabilitation in 3 months from study inclusion and completion of at least 50% (12 sessions) of the program (regular/remote based on allocation) within 6 months from inclusion.
Assessed by a clinical research coordinator from enrollment to 6 months following study initiation.
Secondary Outcomes (16)
Safety of Tele-pulmonary Rehabilitation / Traditional Pulmonary Rehabilitation
Assessed from enrollment to 6 months following study initiation.
Tele-pulmonary Rehabilitation / Traditional Pulmonary Rehabilitation Initiation Rate
Assessed by a clinical research coordinator from enrollment to 6 months following study initiation.
Global Evaluation of Treatment Effectiveness (GETE) score
Will be asked by the clinical research coordinator via phone call after 6 months following study initiation.
Respiratory Symptoms Burden Assessed by CAAT
Assessed by a physician at baseline, and subsequent by the clinical research coordinator via phone call after 6 months following study initiation.
Health Care Utilization
Assessed by a physician at baseline, and subsequent by the clinical research coordinator via phone call after 6 months following study initiation.
- +11 more secondary outcomes
Study Arms (2)
Control
NO INTERVENTIONParticipants in the control group will be sent back to their referring physicians with a recommendation to initiate pulmonary rehabilitation as soon as possible, signed by a pulmonologist. The treating physicians will also be notified.
Tele-Rehabilitation
EXPERIMENTALParticipants will undergo a 12 weeks tele-rehabilitation program using a dedicated application. The intervention consists of 24 online sessions (twice weekly) led by a senior respiratory physiotherapist in groups of up to 5 participants.
Interventions
Participants will undergo a 12 weeks tele-rehabilitation program using a dedicated application. The intervention consists of 24 online sessions (twice weekly) led by a senior respiratory physiotherapist in groups of up to 5 participants. The sessions include: 1. Supervised Exercise: Aerobic and resistance training using household items, stretching, and breathing techniques. 2. Remote Monitoring: Vital signs (heart rate and oxygen saturation) monitored every 10-15 minutes via a study-provided pulse oximeter. 3. Comprehensive Education: Guidance on lifestyle, nutrition, and physical activity. 4. Digital Support: The app provides activity tracking, symptom logging, session reminders, and guided home exercises. At the end of each session, every participant receives a personalized exercise plan based on their performance and preferences, which is displayed in the app.
Eligibility Criteria
You may qualify if:
- Patients meeting the Israeli Health Basket criteria for reimbursement of pulmonary rehabilitation (PR), including one of the following conditions:
- COPD with an FEV1 below 50% or with severe exacerbation (hospitalization) in the previous year or two moderate exacerbations in the previous year.
- Interstitial lung disease with an FVC below 80% or a DLCO below 60%.
- Bronchiectasis with at least two exacerbations in the past year or at least one hospitalization, and an FEV1 below 80%.
- Pulmonary arterial hypertension.
- Willingness to initiate a PR or Tele-PR (TPR) programs.
- Ability to perform the TPR program or traditional PR activities as assessed by a member of the study team prior to enrollment.
- Agree to participate, with signed informed consent.
You may not qualify if:
- Uncontrolled comorbidity (e.g uncontrolled congestive heart failure)
- Inability to operate the mobile application.
- Without a mobile device or computer.
- A hospitalization in the 2-months prior to randomization.
- Completed PR program in the last 12 months.
- Inability to complete 10 repetitions in the 1-minute sit-to-stand test or 5-second single-leg stance
- Pregnancy
- Inability to provide informed consent due to impaired decision-making capacity, as determined by the study's capacity assessment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tel-Aviv Sourasky Medical Centerlead
- Barzilai Medical Centercollaborator
- International Respiratory Coalition (IRC)collaborator
Study Sites (2)
Barzilai Medical Center
Ashkelon, Israel
Tel Aviv Sourasky Medical Center
Tel Aviv, 6423906, Israel
Related Links
- Pulmonary rehabilitation in bronchiectasis: a propensity-matched study
- Pulmonary Rehabilitation Is Associated With Decreased Exacerbation and Mortality in Patients With COPD: A Nationwide Korean Study
- Association Between Initiation of Pulmonary Rehabilitation After Hospitalization for COPD and 1-Year Survival Among Medicare Beneficiaries
- Pulmonary Rehabilitation Utilization in Older Adults with Chronic Obstructive Pulmonary Disease, 2013-2019
- Participation in Pulmonary Rehabilitation after Hospitalization for Chronic Obstructive Pulmonary Disease among Medicare Beneficiaries
- The Need for Expanding Pulmonary Rehabilitation Services
- A blueprint for tele-rehabilitation guidelines
- The Long-Term Maintenance Effect of Remote Pulmonary Rehabilitation via Social Media in COPD: A Randomized Controlled Trial
- The Accessibility, Feasibility, and Safety of a Standardized Community-based Tele-Pulmonary Rehab Program for Chronic Obstructive Pulmonary Disease: A 3-Year Real-World Prospective Study
- Supervised pulmonary tele-rehabilitation versus pulmonary rehabilitation in severe COPD: a randomised multicentre trial
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- All outcomes will be assessed at similar time frames for both the intervention and control groups and filled in an identical form. All phone calls to assess the study outcomes will be performed by research assistances blinded to group allocation. All forms from each phone call will be stored in a single sealed box without details on group allocation. The data extraction from the forms for the study database will be performed at the end of the study by research assistants who will be blinded to group allocation. Statistical analysis will also be done by masking group allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 18, 2026
First Posted
June 24, 2026
Study Start
July 1, 2026
Primary Completion (Estimated)
July 1, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
June 24, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share